| CINF |
Report |
Q2 2026 non-GAAP operating EPS |
BEAT |
pred ~$1.92 vs. cons $1.79 |
MEDIUM |
| CINF |
Report |
Q2 2026 P&C combined ratio |
BEAT |
pred ~96.2% vs. cons 97.4% |
MEDIUM |
| CINF |
Report |
Q2 2026 P&C net written-premium growth |
MISS |
pred ~6% vs. cons 7% |
MEDIUM |
| CINF |
Guide |
Management-implied P&C combined ratio outlook |
BETTER |
guide ~95.6% vs. cons 96.0% (FY2026) |
LOW |
| CINF |
Guide |
Management-implied P&C net written-premium growth outlook |
LOWER |
guide ~6% vs. cons 7% (FY2026) |
MEDIUM |
| CINF |
Guide |
Commercial-lines renewal pricing commentary |
LOWER |
guide ~3% vs. cons 4% (H2 2026) |
MEDIUM |
| CINF |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
MEDIUM |
| CINF |
Return |
5-day cumulative residual |
+0.5% (FADE) |
A catastrophe-aided EPS and combined-ratio beat should initially support the shares, but slower premium growth and commercial pricing of ~3% versus ~4% expected imply modest out-period estimate pressure. With valuation already demanding, the day-1 gain is likely to fade while remaining slightly positive over five days. |
MEDIUM |